CN103830552A - Traditional Chinese medicine composition for treating Meniere's disease - Google Patents
Traditional Chinese medicine composition for treating Meniere's disease Download PDFInfo
- Publication number
- CN103830552A CN103830552A CN201410061282.6A CN201410061282A CN103830552A CN 103830552 A CN103830552 A CN 103830552A CN 201410061282 A CN201410061282 A CN 201410061282A CN 103830552 A CN103830552 A CN 103830552A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- radix
- medicine composition
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 49
- 239000000203 mixture Substances 0.000 title claims abstract description 25
- 208000027530 Meniere disease Diseases 0.000 title abstract description 6
- 239000009636 Huang Qi Substances 0.000 claims abstract description 9
- 239000002994 raw material Substances 0.000 claims description 11
- 241000756943 Codonopsis Species 0.000 claims description 10
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 8
- 241000545442 Radix Species 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 25
- 210000000952 spleen Anatomy 0.000 abstract description 8
- 230000035900 sweating Effects 0.000 abstract description 6
- 210000004072 lung Anatomy 0.000 abstract description 5
- 229940079593 drug Drugs 0.000 abstract description 4
- 238000005728 strengthening Methods 0.000 abstract description 4
- 238000002360 preparation method Methods 0.000 abstract description 3
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- 244000061520 Angelica archangelica Species 0.000 abstract 1
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 1
- 241000218671 Ephedra Species 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 235000001287 Guettarda speciosa Nutrition 0.000 abstract 1
- 235000017443 Hedysarum boreale Nutrition 0.000 abstract 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 abstract 1
- 229930195210 Ophiopogon Natural products 0.000 abstract 1
- 244000248557 Ophiopogon japonicus Species 0.000 abstract 1
- 244000236658 Paeonia lactiflora Species 0.000 abstract 1
- 235000008598 Paeonia lactiflora Nutrition 0.000 abstract 1
- 240000006079 Schisandra chinensis Species 0.000 abstract 1
- 235000008422 Schisandra chinensis Nutrition 0.000 abstract 1
- 239000008186 active pharmaceutical agent Substances 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 abstract 1
- 208000002173 dizziness Diseases 0.000 description 13
- 208000024891 symptom Diseases 0.000 description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 201000010099 disease Diseases 0.000 description 7
- 208000008454 Hyperhidrosis Diseases 0.000 description 6
- 208000012886 Vertigo Diseases 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 208000009205 Tinnitus Diseases 0.000 description 4
- 206010047700 Vomiting Diseases 0.000 description 4
- 238000003745 diagnosis Methods 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 231100000886 tinnitus Toxicity 0.000 description 4
- 231100000889 vertigo Toxicity 0.000 description 4
- 239000003172 expectorant agent Substances 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 210000003462 vein Anatomy 0.000 description 3
- 230000008673 vomiting Effects 0.000 description 3
- 206010013886 Dysaesthesia Diseases 0.000 description 2
- 201000006559 Vertebrobasilar insufficiency Diseases 0.000 description 2
- 201000010861 basilar artery insufficiency Diseases 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000003419 expectorant effect Effects 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 208000035824 paresthesia Diseases 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000000630 rising effect Effects 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 239000011800 void material Substances 0.000 description 2
- 206010063659 Aversion Diseases 0.000 description 1
- 208000012639 Balance disease Diseases 0.000 description 1
- KMYQCELRVANQNG-YXGOVGSCSA-N Br.CN1[C@@H]2C[C@H](O)[C@H]1C[C@H](C2)OC(=O)[C@H](CO)c1ccccc1 Chemical compound Br.CN1[C@@H]2C[C@H](O)[C@H]1C[C@H](C2)OC(=O)[C@H](CO)c1ccccc1 KMYQCELRVANQNG-YXGOVGSCSA-N 0.000 description 1
- JZUFKLXOESDKRF-UHFFFAOYSA-N Chlorothiazide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC2=C1NCNS2(=O)=O JZUFKLXOESDKRF-UHFFFAOYSA-N 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 206010011891 Deafness neurosensory Diseases 0.000 description 1
- 206010061818 Disease progression Diseases 0.000 description 1
- 206010013789 Dry throat Diseases 0.000 description 1
- 208000027601 Inner ear disease Diseases 0.000 description 1
- PWWVAXIEGOYWEE-UHFFFAOYSA-N Isophenergan Chemical compound C1=CC=C2N(CC(C)N(C)C)C3=CC=CC=C3SC2=C1 PWWVAXIEGOYWEE-UHFFFAOYSA-N 0.000 description 1
- 208000017119 Labyrinth disease Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010029216 Nervousness Diseases 0.000 description 1
- 208000012287 Prolapse Diseases 0.000 description 1
- 241000405414 Rehmannia Species 0.000 description 1
- 208000009966 Sensorineural Hearing Loss Diseases 0.000 description 1
- 231100000643 Substance intoxication Toxicity 0.000 description 1
- 206010061373 Sudden Hearing Loss Diseases 0.000 description 1
- 206010070863 Toxicity to various agents Diseases 0.000 description 1
- FNYLWPVRPXGIIP-UHFFFAOYSA-N Triamterene Chemical compound NC1=NC2=NC(N)=NC(N)=C2N=C1C1=CC=CC=C1 FNYLWPVRPXGIIP-UHFFFAOYSA-N 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001427 coherent effect Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 208000013219 diaphoresis Diseases 0.000 description 1
- 230000005750 disease progression Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 231100000880 dysequilibrium Toxicity 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 210000003027 ear inner Anatomy 0.000 description 1
- 210000003060 endolymph Anatomy 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- SMANXXCATUTDDT-QPJJXVBHSA-N flunarizine Chemical compound C1=CC(F)=CC=C1C(C=1C=CC(F)=CC=1)N1CCN(C\C=C\C=2C=CC=CC=2)CC1 SMANXXCATUTDDT-QPJJXVBHSA-N 0.000 description 1
- 229960000326 flunarizine Drugs 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 231100000888 hearing loss Toxicity 0.000 description 1
- 230000010370 hearing loss Effects 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 229960002003 hydrochlorothiazide Drugs 0.000 description 1
- 238000007917 intracranial administration Methods 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 208000008016 pathologic nystagmus Diseases 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 229960003910 promethazine Drugs 0.000 description 1
- 230000007115 recruitment Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 208000023573 sensorineural hearing loss disease Diseases 0.000 description 1
- 239000002893 slag Substances 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 229940125725 tranquilizer Drugs 0.000 description 1
- 239000003204 tranquilizing agent Substances 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 229960001288 triamterene Drugs 0.000 description 1
- 229940124549 vasodilator Drugs 0.000 description 1
- 239000003071 vasodilator agent Substances 0.000 description 1
- 201000000200 vestibular neuronitis Diseases 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese medicine composition for treating Meniere's disease, which is prepared from the following active pharmaceutical ingredients in parts by weight: 10-30 parts of dangshen, 10-30 parts of radix astragali, 5-20 parts of white peony root, 5-20 parts of angelica, 5-20 parts of ophiopogon root, 5-20 parts of cassia twig, 2-10 parts of schisandra fruit, 2-10 parts of honey-fried licorice root and 1-7 parts of ephedra. The traditional Chinese medicine composition provided by the invention has the effects of strengthening the middle-jiao, invigorating qi, tonifying the lung, strengthening the spleen, arresting sweating, dispesing cold, relieving pain, invigorating qi and restoring the pulse, and has obvious curative effect and reliable action on treating Meniere's disease. The traditional Chinese medicine composition has the advantages of wide component drug sources, simple preparation process, mild drug properties and no toxic or side effect.
Description
Technical field
The present invention relates to a kind of medicinal preparation of not determining structure of traditional herbal medicines, especially a kind of Chinese medicine composition for the treatment of Meniere.
Background technology
" Meniere " is a kind of take the dizzy inner ear disease as cardinal symptom, and the endolymph fluid that major lesions is internal ear increases, increased pressure, agnogenio.The symptoms such as that patient Chang Fanfu breaks out is dizzy, nauseating, vomiting, tinnitus and auditory dysesthesia.Because these symptoms are first by French doctor Mei Nier is described, be " Meniere " therefore claim this sick.
Meniere is clinical commonly encountered diseases and frequently-occurring disease.Traditional doctor trained in Western medicine is generally used tranquilizer: as stable, oryzanol, coordinates promethazine; Vasodilator: flunarizine, anisodamine hydrobromide; Diuretic: hydrochlorothiazide; Triamterene.Because there is no etiotropic treatment, doctor trained in Western medicine can not thoroughly be treated this disease, can only respite symptom, and easily recurrence, has a strong impact on patient's normal working and learning.
The traditional Chinese medical science is thought, this genus void of Menieres disease, and sick mark is true, and with the void of spleen kidney, excessive rising of liver-YANG is in the majority.Deficiency-weakness of spleen-QI, water hygroscopic water cloth mistake department, the poly-expectorant that wets into becomes drink, on expectorant is turbid, violates in head, covers and closes key clearly, dizzy, uncomfortable in chest, indigestion and loss of appetite as seen; If old complaint and kidney and insufficiency of kidney-YANG are cold waterborne general, dizzy as seen, foretell the heart and palpitate from nervousness, aversion to cold and cold limbs; If deficiency of the kidney yin, excessive rising of liver-YANG, transformation of fire and occurrence of wind syndrome, disturbs on wind-fire, can be every sends out dizzy because of anxious state of mind, bitter taste in the mouth and dry throat, and liver-wind is held the card of disturbing on expectorant under the arm and is also belonged to common, and clinical in taking medicine according to different syndrome performance choosing sides, can prove effective.
According to theory of Chinese medical science, for the pathogeny of Meniere, carry out dialectical composition of prescription, to reach the object for the treatment of both the principal and secondary aspects of a disease.
Summary of the invention
In order to overcome Meniere's patient in existing technology, Western medicine is existed to temporarily symptom and the undesirable deficiency of therapeutic effect, the invention provides a kind ofly prepare conveniently, medicine source is wide, cost is low, evident in efficacy, reliable effect, a kind of Chinese medicine composition for the treatment of Meniere of having no side effect.
The technical solution adopted for the present invention to solve the technical problems is: a kind of Chinese medicine composition for the treatment of Meniere, is characterized in that: its raw material of Chinese medicine by following weight portion proportioning forms: Radix Codonopsis 10-30 part, Radix Astragali 10-30 part, Radix Paeoniae Alba 5-20 part, Radix Angelicae Sinensis 5-20 part, Radix Ophiopogonis 5-20 part, Ramulus Cinnamomi 5-20 part, Fructus Schisandrae Chinensis 2-10 part, Radix Glycyrrhizae Preparata 2-10 part, Herba Ephedrae 1-7 part.
The preferred technical solution of the present invention is: a kind of Chinese medicine composition for the treatment of Meniere, is characterized in that: its raw material of Chinese medicine by following weight portion proportioning forms: 15 parts of Radix Codonopsis, 15 parts of the Radixs Astragali, 10 parts of the Radix Paeoniae Albas, 10 parts of Radix Angelicae Sinensis, 10 parts of Radix Ophiopogonis, 10 parts of Ramulus Cinnamomi, 6 parts of Fructus Schisandrae Chinensis, 6 parts of Radix Glycyrrhizae Preparatas, 3 parts, Herba Ephedrae.
Chinese medicine composition of the present invention is under Traditional Chinese medical theory and clinical experience guidance, selected medicament composing prescription.In Chinese medicine composition of the present invention: Radix Codonopsis has effect of invigorating the spleen and replenishing QI, spleen invigorating lung benefiting; The Radix Astragali has that benefiting QI for strengthening the superficies, tonifying the lung spleen invigorating, arresting sweating are admittedly de-, wind dispelling is transported malicious effect; The Radix Paeoniae Alba has effect of clear and coherent blood vessels, nourishing blood to suppress the hyperactive liver, slow middle arresting sweating; Radix Angelicae Sinensis have enrich blood invigorate blood circulation, menstruction regulating and pain relieving, effect of loosening bowel to relieve constipation; There is effect that YIN nourishing and the production of body fluid promoting, lung moistening clear away heart-fire Radix Ophiopogonis; Ramulus Cinnamomi has effect of diaphoresis expelling pathogenic factors from muscles, warming the meridian and promoting blood circulation, supporing yang activating QI, dispersing cold for relieving pain; Fructus Schisandrae Chinensis has effect of astringent or styptic treatment for spontaneous sweating, the supplementing QI for promoting the production of body fluid of convergence, kidney calming; Radix Glycyrrhizae Preparata has effect of spleen reinforcing stomach function regulating, Yiqi and vein recovery; Radix Ephedrae has effect of arresting sweating and strengthening superficial resistance.Drug component in the present composition is through dialectical compatibility, complement each other using, there is synergism, play altogether effect of invigorating the spleen and replenishing QI, tonifying the lung spleen invigorating, slow middle arresting sweating, dispersing cold for relieving pain, Yiqi and vein recovery, thereby the treatment of Meniere is reached to the object for the treatment of both the principal and secondary aspects of a disease.
The component of the present composition all adopts natural raw material of Chinese medicine, and its preparation is easy, medicine source is wide, cost is low.It follows the prescriptions principle of the traditional Chinese medical science, and various component drug adopt decocting and take after mixing it with water and take.Through clinical practice checking, it is evident in efficacy
,reliable effect, the property of medicine is gentle, does not occur toxic and side effects, and effective percentage reaches 90%, and cure rate reaches 55%.
The specific embodiment
Below in conjunction with embodiment, the present invention will be further described.
Embodiment 1
Treat a Chinese medicine composition for Meniere, its raw material of Chinese medicine by following weight proportion forms: Radix Codonopsis 15g, Radix Astragali 15g, Radix Paeoniae Alba 10g, Radix Angelicae Sinensis 10g, Radix Ophiopogonis 10g, Ramulus Cinnamomi 10g, Fructus Schisandrae Chinensis 6g, Radix Glycyrrhizae Preparata 6g, Herba Ephedrae 3g.
Embodiment 2
Treat a Chinese medicine composition for Meniere, its raw material of Chinese medicine by following weight proportion forms: Radix Codonopsis 10g, Radix Astragali 25g, Radix Paeoniae Alba 13g, Radix Angelicae Sinensis 20g, Radix Ophiopogonis 5g, Ramulus Cinnamomi 13g, Fructus Schisandrae Chinensis 8g, Radix Glycyrrhizae Preparata 4g, Herba Ephedrae 1g.
Embodiment 3
Treat a Chinese medicine composition for Meniere, its raw material of Chinese medicine by following weight proportion forms: Radix Codonopsis 25g, Radix Astragali 10g, Radix Paeoniae Alba 20g, Radix Angelicae Sinensis 5g, Radix Ophiopogonis 20g, Ramulus Cinnamomi 5g, Fructus Schisandrae Chinensis 4g, Radix Glycyrrhizae Preparata 8g, Herba Ephedrae 5g.
Embodiment 4
Treat a Chinese medicine composition for Meniere, its raw material of Chinese medicine by following weight proportion forms: Radix Codonopsis 30g, Radix Astragali 20g, Radix Paeoniae Alba 16g, Radix Angelicae Sinensis 16g, Radix Ophiopogonis 13g, Ramulus Cinnamomi 16g, Fructus Schisandrae Chinensis 10g, Radix Glycyrrhizae Preparata 2g, Herba Ephedrae 7g.
Embodiment 5
Treat a Chinese medicine composition for Meniere, its raw material of Chinese medicine by following weight proportion forms: Radix Codonopsis 20g, Radix Astragali 30g, Radix Paeoniae Alba 5g, Radix Angelicae Sinensis 13g, Radix Ophiopogonis 16g, Ramulus Cinnamomi 20g, Fructus Schisandrae Chinensis 2g, Radix Glycyrrhizae Preparata 10g, Herba Ephedrae 2g.
Chinese medicine composition in the embodiment of the present invention all decocting method is routinely produced medicament.Concrete grammar is as follows: the raw material of Chinese medicine of prescription is put into container, add cold water and cover powder, soak 15～20 minutes, then add water and do not have approximately 8 centimetres of powder, decoct.At a simmer, adopt intense fire to decoct, after boiling, use slow fire boiling 20～30 minutes; Second decocts, and after water boils, decocts 15～20 minutes.Twice decoction extracting juice that removes slag, merges.
The present invention, with the given a kind of Chinese medicine composition for the treatment of Meniere of embodiment 1, does clinical efficacy and is summarized as follows:
One, general data: this Chinese medicine composition is applied to clinical observation case 60 examples, wherein male 39 examples, female's 21 examples, 36～69 years old age.
Two, diagnostic criteria:
1. the rotatory vertigo of repeatedly showing effect, continues 20 minutes to a few hours.Normal companion disequilibrium, feels sick, vomiting when heavy.Unconscious forfeiture.Visible horizon or horizontal rotary nystagmus transition.The above diagnosis basis that just can do at least shows effect twice;
2. pure-tone audiometer is sensorineural deafness at least one times, and early stage low frequency declines, and listens fluctuation, and with disease progression, hearing loss increases the weight of gradually.Can there is recruitment phenomenon;
3. intermittence or persistence tinnitus, changes before and after onset of vertigo more;
4. ear sensation of fullness;
5. get rid of dizzy that other diseases causes.As positional vertigo, vestibular neuronitis, drug intoxication vertigo, sudden deafness vertigo, it is dizzy that vertebro-basilar artery insufficiency and intracranial spaceoccupying lesion etc. causes.
Three, usage and dosage: when clinical practice, component in the present composition is adopted to the decocting about 250ml that takes concoction for twice, point early, take evening for twice, potion on the one, period in a medicine is avoided pungent, greasy product.
Four, criterion of therapeutical effect:
(1) cure: dizzy and simultaneous phenomenon disappears;
(2) effective: dizzy alleviating, lose and have slight dysequilibrium;
(3) invalid: symptom is without improvement.
Five, therapeutic effect: in this clinical observation case, take medicine 1-6 the course for the treatment of, recovery from illness 33 examples, effective 10 examples, effective 11 examples, invalid 6 examples.During treatment, there is not toxic and side effects.
Six, model case:
Case 1:
Bai, man, 48 years old, first visit: on February 3rd, 2000, main suit: patient is dizzy in prolapse sense in 10 years, tinnitus, auditory dysesthesia, nausea and vomiting, pale complexion, nervously perspire, close order bed, dare not stand up, be auditory vertigo disease through certain hospital diagnosis, take after oryzanol and downern, symptom slightly alleviates, but it is frequent over 10 years, to show effect, every 1-2 day shows effect once, work influenced, this time because of fatigue, feelings will is not relaxed and is occurred above-mentioned symptom;
Check: see that it is light without matter, white and thin fur, examines its deep-rolling pulse
Diagnosis: Meniere's disease (Aural verigo)
Treatment situation: after 1 course for the treatment of medicine, symptom alleviates, is kept to outbreak on the 6th 1 time for 1 time by showing effect original 1-2 day, took again for 1 course for the treatment of, the dizzy not outbreak of private prosecution this month, tinnitus is slow, and audition is as usual, sees tongue normal, arteries and veins bundle relaxes, and takes again for 2 courses for the treatment of to consolidate curative effect, after 6 months, does not follow up a case by regular visits to and does not recur.
Case 2:
Field, female, 69 years old, first visit: on October 6th, 2004, main suit: dizzy more than 10 years, repeatedly show effect over nearly 2 months, accompany general power, become thin, once took Use of Six-flavor Rehmannia Decoction with Additives more than 40 agent at certain hospital outpatient, poor effect, diagnosis: it is dizzy that vertebro-basilar artery insufficiency causes, treatment situation: take medicine 6 days, onset of vertigo alleviates, and spirit takes a turn for the better, and vomiting disappears, can take food, still have mild nausea, weak.Take continuously after 3 courses for the treatment of (3 months), dizzyly do not reaccess always, mental restoration, appetite is promoted.Have rosy cheeks, body weight increases by 3 kilograms, and all diseases are all removed, and follows up a case by regular visits to so far not recurrence.
Claims (2)
1. a Chinese medicine composition for Meniere is sought in treatment, it is characterized in that: its raw material of Chinese medicine by following weight portion proportioning forms: Radix Codonopsis 10-30 part, Radix Astragali 10-30 part, Radix Paeoniae Alba 5-20 part, Radix Angelicae Sinensis 5-20 part, Radix Ophiopogonis 5-20 part, Ramulus Cinnamomi 5-20 part, Fructus Schisandrae Chinensis 2-10 part, Radix Glycyrrhizae Preparata 2-10 part, Herba Ephedrae 1-7 part.
2. a kind of Chinese medicine composition for the treatment of Meniere according to claim 1, is characterized in that: its raw material of Chinese medicine by following weight portion proportioning forms: 15 parts of Radix Codonopsis, 15 parts of the Radixs Astragali, 10 parts of the Radix Paeoniae Albas, 10 parts of Radix Angelicae Sinensis, 10 parts of Radix Ophiopogonis, 10 parts of Ramulus Cinnamomi, 6 parts of Fructus Schisandrae Chinensis, 6 parts of Radix Glycyrrhizae Preparatas, 3 parts, Herba Ephedrae.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410061282.6A CN103830552A (en) | 2014-02-24 | 2014-02-24 | Traditional Chinese medicine composition for treating Meniere's disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410061282.6A CN103830552A (en) | 2014-02-24 | 2014-02-24 | Traditional Chinese medicine composition for treating Meniere's disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103830552A true CN103830552A (en) | 2014-06-04 |
Family
ID=50794654
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410061282.6A Pending CN103830552A (en) | 2014-02-24 | 2014-02-24 | Traditional Chinese medicine composition for treating Meniere's disease |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103830552A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105125675A (en) * | 2014-09-03 | 2015-12-09 | 张士远 | Application of medicine for treating Meniere's vertiginous syndrome |
| CN105287972A (en) * | 2015-11-30 | 2016-02-03 | 覃腾英 | Traditional Chinese medicine composition for curing Meniere's syndrome |
| CN106389891A (en) * | 2016-11-11 | 2017-02-15 | 东莞市百替生物科技有限公司 | Traditional Chinese medicine preparation for curing vertigo and preparation method thereof |
-
2014
- 2014-02-24 CN CN201410061282.6A patent/CN103830552A/en active Pending
Non-Patent Citations (1)
| Title |
|---|
| 朱峻岭等: "《现代神经系统疾病诊断治疗学》", 31 August 2006, 吉林科学技术出版社 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105125675A (en) * | 2014-09-03 | 2015-12-09 | 张士远 | Application of medicine for treating Meniere's vertiginous syndrome |
| CN105287972A (en) * | 2015-11-30 | 2016-02-03 | 覃腾英 | Traditional Chinese medicine composition for curing Meniere's syndrome |
| CN106389891A (en) * | 2016-11-11 | 2017-02-15 | 东莞市百替生物科技有限公司 | Traditional Chinese medicine preparation for curing vertigo and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103784887A (en) | Traditional Chinese medicinal composition for treating kidney deficiency lumbago | |
| CN103055116B (en) | Traditional Chinese medicine composition for treating acnes | |
| CN103550687B (en) | A kind of Chinese medicine composition for the treatment of the hepatic and renal YIN deficiency | |
| CN104013910A (en) | Traditional Chinese medicine composition for treating hypertension | |
| CN105288208A (en) | Traditional Chinese medicine composition for treating acute optic neuritis | |
| CN103830552A (en) | Traditional Chinese medicine composition for treating Meniere's disease | |
| CN102961561B (en) | Chinese medicinal composition for treating coronary heart disease | |
| CN103316250B (en) | Traditional Chinese medicine composition for treating cardiopalmus | |
| CN103007217B (en) | Chinese medicinal composition for treating hypotension | |
| CN104606561A (en) | Traditional Chinese medicinal composition for treating spontaneous perspiration | |
| CN103223139A (en) | Traditional Chinese medicinal composition for treating chronic ulcerative colitis | |
| CN103463397B (en) | Traditional Chinese medicine composition for treating deficiency of kidney-yin | |
| CN104117018A (en) | Traditional Chinese medicine composition for treating coronary heart disease | |
| CN105148235A (en) | Traditional Chinese medicine combination treating postpartum hemorrhage | |
| CN104623330A (en) | Chinese medicinal composition for treating hyperlipidemia | |
| CN103285108B (en) | Chinese medicinal composition treating lumbago | |
| CN103211998B (en) | Traditional Chinese medicine composition for treatment of yin deficiency and yang excess | |
| CN103223113B (en) | Traditional Chinese medicine composition for treating functional uterine bleeding | |
| CN103356951B (en) | A kind of Chinese medicine composition for the treatment of cardiac blood supply deficiency | |
| CN103816493B (en) | A kind of Chinese medicine composition treating instability of kidney QI | |
| CN103028063B (en) | Traditional Chinese medicine composition for treating nephropathy | |
| CN101229277A (en) | Medicine compounds for treating leukemia | |
| CN105998738A (en) | Traditional Chinese medicinal composition for treating night sweat | |
| CN104056196A (en) | Traditional Chinese medicine composition for treating bradycardia | |
| CN105079514A (en) | Traditional Chinese medicine composition for treating dizziness |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140604 |